Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Virtus

Virtus Ceredex Mid-Cap Value Equity Fund Class I (SMVTX)

Ticker SMVTX · · Holdings as of Jun 30, 2026

Expense ratio
0.99%$99/yr per $10k
5-yr return
+9.8%annualized
1-yr return
+17.7%as of Dec 2025
Net assets
$1.3Ball share classes
Holdings
61

Bottom line

Is SMVTX a good fund? The bottom line

SMVTX is the Class I share class of Virtus Ceredex Mid-Cap Value Equity Fund, an actively managed mid-cap mutual fund from Virtus.

Annual fees run 0.99% — about $99 a year on every $10,000 invested, more expensive than 61% of mid-cap funds we track.

It returned +17.7% over one year, +9.8% a year over five years, +10.0% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.3 billion in net assets and 61 holdings, its largest position is Arthur J. Gallagher & Company (1.9%) and the top 10 make up 18.1% of the portfolio.

What stands out

  • 5-year return beat 74% of category peers
  • No front-end sales load

What to watch

  • High turnover (192% a year) can mean more taxable distributions

Updated Nov 19, 2026

What SMVTX invests in

The fund has an investment objective of seeking to provide capital appreciation. As a secondary goal, the fund also seeks to provide current income.

Under normal circumstances, the fund invests at least 80% of its net assets in U.S.-traded equity securities of mid-capitalization companies. U.S.-traded equity securities may include American Depositary Receipts (ADRs). As of the date of this prospectus, the funds subadviser considers mid-capitalization companies for this purpose to be those companies that, at the time of initial purchase, have market capitalizations generally within the range of companies included in the Russell Midcap Index. O As of June 30, 2026, the market capitalization range of the companies in the Russell Midcap Index was $777 million to $92.7 billion. As a result of its investment strategy, the funds portfolio turnover rate may be 100% or more and the fund may focus its investments in one or more sectors. In selecting investments for purchase and sale, the subadviser chooses companies that it believes are…

From the fund's prospectus (filed Sep 25, 2026).

SMVTX performance

Fund calendar-year total returns, 2016–2025 2016: +20.2%; 2017: +11.7%; 2018: −7.8%; 2019: +33.1%; 2020: −1.2%; 2021: +29.0%; 2022: −13.9%; 2023: +11.0%; 2024: +10.0%; 2025: +17.7% +20% 2016 +12% 2017 −8% 2018 +33% 2019 −1% 2020 +29% 2021 −14% 2022 +11% 2023 +10% 2024 +18% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
SMVTX+17.7%+9.8%+10.0%
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full SMVTX performance history →

What SMVTX costs

On a $10,000 investment, SMVTX's 0.99% expense ratio costs about $99 a year. The prospectus estimates $1,266 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full SMVTX fee table →

SMVTX top 10 holdings

#Holding% of fund
1Arthur J. Gallagher & Company AJG1.89%
2Cardinal Health Inc CAH1.87%
3L3harris Technologies Inc LHX1.84%
4Teradyne Inc TER1.81%
5Nvent Electric Plc NVT1.80%
6Sensient Technologies Corp SXT1.80%
7American Electric Power Company Inc AEP1.79%
8Solstice Advanced Materials Inc SOLS1.79%
9Entegris Inc ENTG1.75%
10Evercore Inc EVR1.74%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 18.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to SMVTX

More funds like SMVTX →

SMVTX FAQ

What is the expense ratio of SMVTX?
SMVTX's expense ratio is 0.99%, which works out to about $99 a year for every $10,000 invested. The prospectus estimates total costs of $1,266 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is SMVTX a good investment?
It depends on your goals, but the data points to: 5-year return beat 74% of category peers; no front-end sales load; high turnover (192% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does SMVTX hold?
SMVTX's largest holdings are Arthur J. Gallagher & Company (1.9%), Cardinal Health Inc (1.9%), L3harris Technologies Inc (1.8%), Teradyne Inc (1.8%), Nvent Electric Plc (1.8%). It holds 61 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is SMVTX's 5-year return?
SMVTX returned +9.8% a year over the five years ending Dec 31, 2025, and +10.0% a year over ten years. Past performance does not guarantee future results.
Does SMVTX have a sales load?
No. SMVTX has no front-end sales charge.
Who manages SMVTX?
SMVTX is offered by Virtus through Virtus Asset Trust.